478 related articles for article (PubMed ID: 12742638)
1. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
[TBL] [Abstract][Full Text] [Related]
3. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
[TBL] [Abstract][Full Text] [Related]
4. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
Uphouse L; Maswood S; Jackson A
Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
[TBL] [Abstract][Full Text] [Related]
5. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
Trevino A; Wolf A; Jackson A; Price T; Uphouse L
Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
[TBL] [Abstract][Full Text] [Related]
6. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Jackson A; Uphouse L
Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
[TBL] [Abstract][Full Text] [Related]
7. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
Jackson A; Etgen AM
Pharmacol Biochem Behav; 2001 Feb; 68(2):221-7. PubMed ID: 11267626
[TBL] [Abstract][Full Text] [Related]
8. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior.
Uphouse L; White S; Harrison L; Hiegel C; Majumdar D; Guptarak J; Truitt WA
Pharmacol Biochem Behav; 2003 Aug; 76(1):63-73. PubMed ID: 13679218
[TBL] [Abstract][Full Text] [Related]
9. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
Selvamani A; Lincoln C; Uphouse L
Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1A receptor antagonists and lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
Jackson A; Uphouse L
Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
Wolf A; Jackson A; Price T; Trevino A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Sep; 804(2):206-11. PubMed ID: 9757039
[TBL] [Abstract][Full Text] [Related]
13. Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.
Uphouse L; Hiegel C; Guptarak J; Maswood N
Horm Behav; 2009 Jan; 55(1):169-74. PubMed ID: 18952090
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
[TBL] [Abstract][Full Text] [Related]
15. Serotonin receptor involvement in effects of restraint on female rat lordosis behavior.
Uphouse L; Hiegel C; Perez E; Guptarak J
Pharmacol Biochem Behav; 2007 Apr; 86(4):631-6. PubMed ID: 17368527
[TBL] [Abstract][Full Text] [Related]
16. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
Guptarak J; Selvamani A; Uphouse L
Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
[TBL] [Abstract][Full Text] [Related]
17. WAY100635 and female rat lordosis behavior.
Uphouse L; Wolf A
Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
[TBL] [Abstract][Full Text] [Related]
18. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
[TBL] [Abstract][Full Text] [Related]
19. Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior.
Maswood N; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Aug; 802(1-2):98-103. PubMed ID: 9748522
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the serotonin1A agonist, 8-OH-DPAT, on masculine and feminine sexual behavior of the ferret.
Paredes RG; Kica E; Baum MJ
Psychopharmacology (Berl); 1994 May; 114(4):591-6. PubMed ID: 7855220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
